Literature DB >> 29437975

Differential Delivery of Genomic Double-Stranded RNA Causes Reovirus Strain-Specific Differences in Interferon Regulatory Factor 3 Activation.

Johnasha D Stuart1,2, Geoffrey H Holm3, Karl W Boehme4,2.   

Abstract

Serotype 3 (T3) reoviruses induce substantially more type 1 interferon (IFN-I) secretion than serotype 1 (T1) strains. However, the mechanisms underlying differences in IFN-I production between T1 and T3 reoviruses remain undefined. Here, we found that differences in IFN-I production between T1 and T3 reoviruses correlate with activation of interferon regulatory factor 3 (IRF3), a key transcription factor for the production of IFN-I. T3 strain rsT3D activated IRF3 more rapidly and to a greater extent than the T1 strain rsT1L, in simian virus 40 (SV40) immortalized endothelial cells (SVECs). Differences in IRF3 activation between rsT1L and rsT3D were observed in the first hours of infection and were independent of de novo viral RNA and protein synthesis. NF-κB activation mirrored IRF3 activation, with rsT3D inducing more NF-κB activity than rsT1L. We also found that IRF3 and NF-κB are activated in a mitochondrial antiviral-signaling protein (MAVS)-dependent manner. rsT1L does not suppress IRF3 activation, as IRF3 phosphorylation could be induced in rsT1L-infected cells. Transfected rsT1L and rsT3D RNA induced IRF3 phosphorylation, indicating that genomic RNA from both strains has the capacity to activate IRF3. Finally, bypassing the normal route of reovirus entry by transfecting in vitro-generated viral cores revealed that rsT1L and rsT3D core particles induced equivalent IRF3 activation. Taken together, our findings indicate that entry-related events that occur after outer capsid disassembly, but prior to deposition of viral cores into the cytoplasm, influence the efficiency of IFN-I responses to reovirus. This work provides further insight into mechanisms by which nonenveloped viruses activate innate immune responses.IMPORTANCE Detection of viral nucleic acids by the host cell triggers type 1 interferon (IFN-I) responses, which are critical for containing and clearing viral infections. Viral RNA is sensed in the cytoplasm by cellular receptors that initiate signaling pathways, leading to the activation of interferon regulatory factor 3 (IRF3) and NF-κB, key transcription factors required for IFN-I induction. Serotype 3 (T3) reoviruses induce significantly more IFN-I than serotype 1 (T1) strains. In this work, we found that differences in IFN-I production by T1 and T3 reoviruses correlate with differential IRF3 activation. Differences in IRF3 activation are not caused by a blockade of the IRF3 activation by a T1 strain. Rather, differences in events during the late stages of viral entry determine the capacity of reovirus to activate host IFN-I responses. Together, our work provides insight into mechanisms of IFN-I induction by nonenveloped viruses.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  IRF3; double-stranded RNA virus; recombinant virus; reovirus; type 1 interferon

Mesh:

Substances:

Year:  2018        PMID: 29437975      PMCID: PMC5899194          DOI: 10.1128/JVI.01947-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

Review 1.  Attachment and cell entry of mammalian orthoreovirus.

Authors:  K M Guglielmi; E M Johnson; T Stehle; T S Dermody
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

2.  Peptides released from reovirus outer capsid form membrane pores that recruit virus particles.

Authors:  Tijana Ivanovic; Melina A Agosto; Lan Zhang; Kartik Chandran; Stephen C Harrison; Max L Nibert
Journal:  EMBO J       Date:  2008-03-27       Impact factor: 11.598

Review 3.  Viral strategies of immune evasion.

Authors:  H L Ploegh
Journal:  Science       Date:  1998-04-10       Impact factor: 47.728

4.  Conformational changes required for reovirus cell entry are sensitive to pH.

Authors:  Deepti Thete; Pranav Danthi
Journal:  Virology       Date:  2015-05-22       Impact factor: 3.616

5.  Junction adhesion molecule is a receptor for reovirus.

Authors:  E S Barton; J C Forrest; J L Connolly; J D Chappell; Y Liu; F J Schnell; A Nusrat; C A Parkos; T S Dermody
Journal:  Cell       Date:  2001-02-09       Impact factor: 41.582

6.  Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles.

Authors:  D B Furlong; M L Nibert; B N Fields
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

7.  Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein micro 1 mediates membrane disruption.

Authors:  Kartik Chandran; Diane L Farsetta; Max L Nibert
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Retinoic acid-inducible gene-I and interferon-beta promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3.

Authors:  Geoffrey H Holm; Jennifer Zurney; Vanessa Tumilasci; Simon Leveille; Pranav Danthi; John Hiscott; Barbara Sherry; Terence S Dermody
Journal:  J Biol Chem       Date:  2007-05-31       Impact factor: 5.157

9.  Prevalence of reovirus-specific antibodies in young children in Nashville, Tennessee.

Authors:  Jennifer H Tai; John V Williams; Kathryn M Edwards; Peter F Wright; James E Crowe; Terence S Dermody
Journal:  J Infect Dis       Date:  2005-03-08       Impact factor: 5.226

Review 10.  Cytosolic sensing of viruses.

Authors:  Delphine Goubau; Safia Deddouche; Caetano Reis e Sousa
Journal:  Immunity       Date:  2013-05-23       Impact factor: 31.745

View more
  10 in total

1.  Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase Inhibitors.

Authors:  Roxana M Rodríguez Stewart; Jameson T L Berry; Angela K Berger; Sung Bo Yoon; Aspen L Hirsch; Jaime A Guberman; Nirav B Patel; Gregory K Tharp; Steven E Bosinger; Bernardo A Mainou
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

2.  Early Events in Reovirus Infection Influence Induction of Innate Immune Response.

Authors:  Andrew T Abad; Pranav Danthi
Journal:  J Virol       Date:  2022-07-06       Impact factor: 6.549

3.  Reovirus Efficiently Reassorts Genome Segments during Coinfection and Superinfection.

Authors:  Timothy W Thoner; Madeline M Meloy; Jacob M Long; Julia R Diller; James C Slaughter; Kristen M Ogden
Journal:  J Virol       Date:  2022-09-12       Impact factor: 6.549

4.  Mammalian Orthoreovirus Reassortment Proceeds with Little Constraint on Segment Mixing.

Authors:  Megan R Hockman; Nathan T Jacobs; Bernardo A Mainou; Katia Koelle; Anice C Lowen
Journal:  J Virol       Date:  2021-12-22       Impact factor: 6.549

5.  The Reovirus σ3 Protein Inhibits NF-κB-Dependent Antiviral Signaling.

Authors:  Andrew J McNamara; Austin D Brooks; Pranav Danthi
Journal:  J Virol       Date:  2022-04-13       Impact factor: 6.549

Review 6.  Recognition of Reovirus RNAs by the Innate Immune System.

Authors:  Andrew T Abad; Pranav Danthi
Journal:  Viruses       Date:  2020-06-20       Impact factor: 5.048

Review 7.  Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection.

Authors:  Tarryn Bourhill; Yoshinori Mori; Derrick E Rancourt; Maya Shmulevitz; Randal N Johnston
Journal:  Viruses       Date:  2018-08-11       Impact factor: 5.048

Review 8.  Current understanding of reovirus oncolysis mechanisms.

Authors:  Matthew B Phillips; Johnasha D Stuart; Roxana M Rodríguez Stewart; Jameson Tl Berry; Bernardo A Mainou; Karl W Boehme
Journal:  Oncolytic Virother       Date:  2018-06-14

9.  Vesicular trafficking permits evasion of cGAS/STING surveillance during initial human papillomavirus infection.

Authors:  Brittany L Uhlorn; Robert Jackson; Shuaizhi Li; Shauna M Bratton; Koenraad Van Doorslaer; Samuel K Campos
Journal:  PLoS Pathog       Date:  2020-11-30       Impact factor: 6.823

Review 10.  The gamble between oncolytic virus therapy and IFN.

Authors:  Qingbo Li; Fengxian Tan; Yuanyuan Wang; Xiaohui Liu; Xianbin Kong; Jingyan Meng; Long Yang; Shan Cen
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.